Pfizer Requests Approval to Use COVID-19 Vaccine for Teens

Pfizer Inc. has requested that the U.S. Food and Drug Administration amend the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine to authorize its use in adolescents 12 to 15 years of age. Phase 3 trials demonstrated 100% efficacy and robust antibody response after vaccination. Click here for more.  

Scroll to Top